Delivery Order #SPE2D226F1419

Delivery Order for Erythromycin Ophthalmic from DMS Pharmaceutical Group

This award represents a definitive delivery order contract to DMS Pharmaceutical Group Inc., a recognized pharmaceutical manufacturer and distributor, focusing on the provision of Erythromycin Ophthalmic medication. The contract is a part of an existing substantial indefinite delivery vehicle (IDV) that DMS holds, which covers a broad spectrum of essential pharmaceuticals for government health agencies. The significance of this order is highlighted by its role in supporting ongoing government healthcare initiatives that require reliable access to critical medications. The scope includes the timely delivery of erythromycin ophthalmic ointment, used for treating eye infections, ensuring continuous supply to meet medical needs. This delivery order was issued under the umbrella of a competitively awarded IDV, ensuring compliance with procurement regulations and fostering fair competition. The contract performance is scheduled for a single-day delivery, fitting into the longer-term agreement commencing mid-2025. While no key subcontractors or previous related contracts were specified for this individual order, its linkage to the larger contract underscores the comprehensive pharmaceutical provision strategy employed by the agency.

Description

8511957030!ERYTHROMYCIN OPHTHA

View original record